Founding cohort participants will receive:

• Comprehensive initial assessment (60–90 minutes)

• Structured risk stratification and treatment planning

• Ongoing follow-up with defined intervals

• Direct access for clinical questions and adjustment of care

Care will follow the same clinical framework outlined across AthenaVita, with particular emphasis on:

• Early trajectory identification

• Measurable physiologic targets

• Continuous reassessment and modification

The cohort will serve as the initial implementation of:

• Cardiometabolic risk identification during the menopause transition

• Integration of sex-specific risk factors into standard cardiovascular assessment

• Structured use of pharmacologic interventions when indicated (including GLP-1 therapy and hormone therapy within defined parameters)

• Preservation of metabolic function and lean mass

Outcomes will be tracked longitudinally to evaluate:

• Risk score modification

• Lipid and metabolic trends

• Blood pressure patterns

• Symptom burden and quality-of-life measures

This cohort is appropriate for women who:

• Are in perimenopause or early postmenopause

• Recognize physiologic changes not addressed in traditional care

• Are willing to engage in a structured, data-driven approach

• Prefer a defined clinical model over generalized guidance

Participation requires:

• Engagement with recommended monitoring and follow-up

• Willingness to implement and adjust interventions over time

This is not episodic or one-time care.
It is a longitudinal prevention model.

The founding cohort is offered at a fixed rate:

$4,800 for six months of care

This includes:

• Comprehensive initial assessment

• Ongoing follow-up and clinical management

• Direct provider access for care-related communication

• Longitudinal tracking and adjustment of interventions

Payment is made in full at enrollment. This reflects the intensity of the initial assessment phase, level of access and continuity provided, and structure of care delivery within the model.

This investment covers clinical services provided through AthenaVita.

It does not include:

• Laboratory testing

• Medications

• Imaging studies

• External specialist care

AthenaVita operates outside of insurance-based models. However, AthenaVita services may be eligible for HSA/FSA reimbursement, depending on your plan. Documentation may be requested for patient submission.